
Cancer cells and cells of the tumor microenvironment (TME) show extensive biochemical alterations, which provide multiple opportunities for developing innovative strategies for diagnosis, therapy, and prognosis. The disrupted metabolism of cancer cells (1) and immune cells of the TME (2) is controlled by several protein families. As such, it is not surprising that many of them have their cellular levels significantly increased or decreased. In the first volume of the Research Topic "Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets", we provided an update on proteins whose cellular levels are altered in cancer, highlighting their promise for diagnosis and therapy.The second volume of this Research Topic complements the first one. It contains 9 original research articles and 5 review articles. In the following sections, we summarize the main concepts and findings of these studies, grouped according to the main physiological or pathological role of each protein.
Proteins with altered cellular levels in cancer cells include those regulating gene These studies exemplify the multiple direct and indirect players involved in gene expression and their complex regulation, whose disruption in cancer cells affects the levels of messenger RNA (mRNA) and translated proteins.
Cellular levels of functional proteins are also determined by the equilibrium between their phosphorylation and degradation. These processes, also governed by proteins, can be disrupted in cancer cells. Pidkovka and Belkhiri reviewed the impact of the up-regulated transmembrane AXL receptor tyrosine kinase in gastrointestinal cancers and its potential role as a therapeutic target. Inhibition of this protein with small molecules or antibodies is currently being investigated in several clinical trials. In addition, Tang et al. reviewed the relevance of intracellular non-receptor protein tyrosine phosphatases across multiple cancer histologies. Some of these proteins seem to play a dual role in specific cancer types. They are also emerging as targets for immunotherapy and specific These studies introduce novel strategies to interfere with cell division or to induce apoptosis, which provide promising outcomes against uncontrolled proliferation, the most distinctive feature of cancer cells.
The effects of altered protein levels can reach beyond their cell of origin. Through These studies demonstrate that proteins related to the propagation of cancer features are promising tools for diagnosis and prognosis.
The data reported in the present Research Topic provide novel data about regulatory proteins expressed in cancer cells and in immune cells of the TME.These regulatory proteins can control not only primary tumor growth and metastasis but also the efficiency of anti-cancer therapies. These proteins include transcription factors, which affect the levels of transcribed mRNA and translated protein. They also include enzymes involved in protein phosphorylation, dephosphorylation, and degradation, whose altered expression deregulates the levels of functional proteins (Figure 1A). These alterations can affect processes including cell division and apoptosis (Figure 1B). Altered protein levels can exert effects on a larger scale, by modifying the TME and promoting tumor angiogenesis (Figure 1C).




